It suggests that BTG1 deletions may act as “drivers” of leukemogenesis in BCP-ALL, MPAL, and lymphoid CML-BC (B-lineage) with Ph. The gene discussed is BTG1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.